Have a personal or library account? Click to login
Expression of IL-1β, IL-6 and TNF-α in rats with thioacetamide-induced acute liver failure and encephalopathy: correlation with brain edema Cover

Expression of IL-1β, IL-6 and TNF-α in rats with thioacetamide-induced acute liver failure and encephalopathy: correlation with brain edema

Open Access
|Feb 2017

References

  1. 1. Aggarwal S, Kramer D, Yonas H, Obrist W, Kang Y, Martin M, et al. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study. Hepatology. 1994; 19:80-7.10.1002/hep.1840190114
  2. 2. Hazell AS, Butterworth RF. Hepatic encephalopathy: An update of pathophysiologic mechanisms. Proc Soc Exp Biol Med. 1999; 222:99-112.10.1046/j.1525-1373.1999.d01-120.x
  3. 3. Lewis M, Howdle PD. The neurology of liver failure. QJM. 2003; 96:623-33.10.1093/qjmed/hcg110
  4. 4. Shawcross D, Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci. 2005; 62:2295-304.10.1007/s00018-005-5089-0
  5. 5. Cooper AJ, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev. 1987; 67:440-519.10.1152/physrev.1987.67.2.440
  6. 6. Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003; 125:755-64.10.1016/S0016-5085(03)01051-5
  7. 7. Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol. 2004; 40: 247-54.10.1016/j.jhep.2003.10.01614739095
  8. 8. Rolando N, Wade J, Davalos M, Wendon J, Philpott- Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000; 32:734-9.10.1053/jhep.2000.1768711003617
  9. 9. Chu CJ, Wang SS, Lee FY, Chang FY, Lin HC, Hou MC, et al. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamideinduced fulminant hepatic failure. Eur J Clin Invest. 2001; 31:156-63.10.1046/j.1365-2362.2001.00775.x11168455
  10. 10. Zimmermann C, Ferenci P, Pifl C, Yurdaydin C, Ebner J, Lassmann H, et al. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology. 1989; 9:594-601.10.1002/hep.18400904142564368
  11. 11. Reddy PV, Murthy C, Reddanna P. Fulminant hepatic failure induced oxidative stress in nonsynaptic mitochondria of cerebral cortex in rats. Neurosci Lett. 2004; 368:15-20.10.1016/j.neulet.2004.06.046
  12. 12. Swapna I, Kumar KV, Reddy PV, Murthy C, Reddanna P, Senthilkumaran B. Phospholipid and cholesterol alterations accompany structural disarray in myelin membrane of rats with hepatic encephalopathy induced by thioacetamide. Neurochem Int. 2006; 49:238-44.10.1016/j.neuint.2006.01.012
  13. 13. Norton NS, McConnell JR, Rodriguez-Sierra JF. Behavioral and physiological sex differences observed in an animal model of fulminant hepatic encephalopathy in the rat. Physiol Behav. 1997; 62:1113-24.10.1016/S0031-9384(97)00267-9
  14. 14. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature. 2001; 413:527-31.10.1038/35097089
  15. 15. Fride E, Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur J Pharmacol. 1993; 231:313-4.10.1016/0014-2999(93)90468-W
  16. 16. Zhan C, Yang J. Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacol Res. 2006; 53:303-9.10.1016/j.phrs.2005.12.00816459097
  17. 17. Schnur J, Olah J, Szepesi A, Nagy P, Thorgeirsson SS. Thioacetamide-induced hepatic fibrosis in transforming growth factor beta-1 transgenic mice. Eur J Gastroenterol Hepatol. 2004; 16:127-33.10.1097/00042737-200402000-0000215075984
  18. 18. Honda H, Ikejima K, Hirose M, Yoshikawa M, Lang T, Enomoto N, et al. Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology. 2002; 36:12-21.10.1053/jhep.2002.3368412085344
  19. 19. Chu CJ, Chen CT, Wang SS, Lee FY, Chang FY, Lin HC, et al. Hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of endotoxin and tumor necrosis factor-alpha. Zhonghua Yi Xue Za Zhi (Taipei). 2001; 64:321-30.
  20. 20. Kato M, Hughes RD, Keays RT, Williams R. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology. 1992; 15:1060-6.10.1002/hep.18401506151592344
  21. 21. Maness LM, Kastin AJ, Farrell CL, Banks WA. Fate of leptin after intracerebroventricular injection into the mouse brain. Endocrinology. 1998; 139:4556-62.10.1210/endo.139.11.63199794465
DOI: https://doi.org/10.5372/1905-7415.0502.026 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 205 - 215
Published on: Feb 4, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2017 Li-Qing Wang, Heng-Jun Zhou, Cai-Fei Pan, Sheng-Mei Zhu, Lin-Mei Xu, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.